跳至主要内容
临床试验/EUCTR2006-001337-17-DE
EUCTR2006-001337-17-DE进行中(未招募)不适用

Characterisation of multiple sclerosis pathology by ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques[Charakterisierung der Multiple Sklerose Pathologie durch ultra small particles of iron oxide (USPIO)” im Vergleich zu konventionellen und fortgeschrittenen MRT Techniken] - MS_USPIO_MPIP

Max-Planck-Institute of Psychiatry0 个研究点开始时间: 2007年3月26日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a. clinically definite MS acc. to McDonald's criteria for the MS group (N=90)
  • b. clinically isolated syndrome compatible with MS, no definite diagnosis of MS (for CIS patients, N=15)
  • b. age over or equal 18 years
  • d. cognitive abilities to give informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • a. Age below 18 years
  • b. Pregnancy
  • c. Withdrawal of consent
  • d. hypersensitivity to dextrane

研究者

发起方
Max-Planck-Institute of Psychiatry

相似试验